Treace Medical Concepts Statistics
Total Valuation
TMCI has a market cap or net worth of $282.56 million. The enterprise value is $317.61 million.
Important Dates
The last earnings date was Friday, November 6, 2026, before market open.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TMCI has 65.56 million shares outstanding. The number of shares has increased by 2.95% in one year.
| Current Share Class | 65.56M |
| Shares Outstanding | 65.56M |
| Shares Change (YoY) | +2.95% |
| Shares Change (QoQ) | +0.64% |
| Owned by Insiders (%) | 26.23% |
| Owned by Institutions (%) | 39.25% |
| Float | 48.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.39 |
| Forward PS | 1.30 |
| PB Ratio | 4.58 |
| P/TBV Ratio | 6.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.58, with a Debt / Equity ratio of 1.21.
| Current Ratio | 2.58 |
| Quick Ratio | 1.53 |
| Debt / Equity | 1.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.17 |
Financial Efficiency
Return on equity (ROE) is -73.98% and return on invested capital (ROIC) is -20.93%.
| Return on Equity (ROE) | -73.98% |
| Return on Assets (ROA) | -16.49% |
| Return on Invested Capital (ROIC) | -20.93% |
| Return on Capital Employed (ROCE) | -37.22% |
| Weighted Average Cost of Capital (WACC) | 11.50% |
| Revenue Per Employee | $451,880 |
| Profits Per Employee | -$123,987 |
| Employee Count | 450 |
| Asset Turnover | 1.08 |
| Inventory Turnover | 0.99 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +58.46% in the last 52 weeks. The beta is 1.56, so TMCI's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | +58.46% |
| 50-Day Moving Average | 4.41 |
| 200-Day Moving Average | 3.40 |
| Relative Strength Index (RSI) | 46.14 |
| Average Volume (20 Days) | 344,597 |
Short Selling Information
The latest short interest is 1.79 million, so 2.73% of the outstanding shares have been sold short.
| Short Interest | 1.79M |
| Short Previous Month | 1.92M |
| Short % of Shares Out | 2.73% |
| Short % of Float | 3.70% |
| Short Ratio (days to cover) | 8.19 |
Income Statement
In the last 12 months, TMCI had revenue of $203.35 million and -$55.79 million in losses. Loss per share was -$0.86.
| Revenue | 203.35M |
| Gross Profit | 161.77M |
| Operating Income | -49.58M |
| Pretax Income | -55.79M |
| Net Income | -55.79M |
| EBITDA | -42.95M |
| EBIT | -49.58M |
| Loss Per Share | -$0.86 |
Full Income Statement Balance Sheet
The company has $39.80 million in cash and $74.85 million in debt, with a net cash position of -$35.05 million or -$0.53 per share.
| Cash & Cash Equivalents | 39.80M |
| Total Debt | 74.85M |
| Net Cash | -35.05M |
| Net Cash Per Share | -$0.53 |
| Equity (Book Value) | 61.65M |
| Book Value Per Share | 0.94 |
| Working Capital | 72.61M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$8.74 million and capital expenditures -$9.83 million, giving a free cash flow of -$18.57 million.
| Operating Cash Flow | -8.74M |
| Capital Expenditures | -9.83M |
| Depreciation & Amortization | 6.63M |
| Net Borrowing | 2.90M |
| Free Cash Flow | -18.57M |
| FCF Per Share | -$0.28 |
Full Cash Flow Statement Margins
Gross margin is 79.55%, with operating and profit margins of -24.38% and -27.44%.
| Gross Margin | 79.55% |
| Operating Margin | -24.38% |
| Pretax Margin | -27.44% |
| Profit Margin | -27.44% |
| EBITDA Margin | -21.12% |
| EBIT Margin | -24.38% |
| FCF Margin | n/a |
Dividends & Yields
TMCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.95% |
| Shareholder Yield | -2.95% |
| Earnings Yield | -19.99% |
| FCF Yield | -6.57% |
Analyst Forecast
The average price target for TMCI is $6.17, which is 43.09% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.17 |
| Price Target Difference | 43.09% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 3.32% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMCI has an Altman Z-Score of -0.48 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.48 |
| Piotroski F-Score | 2 |